Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Opiant Pharmaceuticals Inc (OTCQB:OPNT)

7.80
Delayed Data
As of 3:40pm ET
 -0.355 / -4.35%
Today’s Change
5.01
Today|||52-Week Range
11.75
+39.04%
Year-to-Date
Drug Addiction Treatment Stocks to Watch
Feb 22 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close8.15
Today’s open8.14
Day’s range7.78 - 8.14
Volume6,352
Average volume (3 months)4,504
Market cap$16.6M
Dividend yield--
Data as of 3:40pm ET, 02/27/2017

Growth & Valuation

Earnings growth (last year)-134.36%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+538.55%
P/E ratioNM
Price/Sales1.51
Price/Book--

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$9.9M
Annual profit (last year)-$7.8M
Net profit margin-78.95%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Head-Media Relations
Roger Crystal
CFO, Secretary, Treasurer &
Director
Kevin A. Pollack
Corporate headquarters
Santa Monica, California

Forecasts


Search for Jobs